Cargando…
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
ISSUES: Cessation of methamphetamine use may result in a characteristic withdrawal syndrome, no medication has been approved for this indication. This systematic review aims to assess the efficacy of pharmacotherapy for methamphetamine withdrawal, the first comprehensive meta‐analysis since 2008. AP...
Autores principales: | Acheson, Liam S., Williams, Benjamin H., Farrell, Michael, McKetin, Rebecca, Ezard, Nadine, Siefried, Krista J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083934/ https://www.ncbi.nlm.nih.gov/pubmed/35862266 http://dx.doi.org/10.1111/dar.13511 |
Ejemplares similares
-
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022) -
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020) -
Patterns of smoking and injecting methamphetamine and their association with health and social outcomes
por: McKetin, Rebecca, et al.
Publicado: (2021) -
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
por: Siefried, Krista J., et al.
Publicado: (2021) -
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018)